家族性脑海绵状血管瘤患者的癫痫发作发病率
研究基于脑血管畸形联盟(BVMC)中479例家族性脑海绵状血管瘤(FCCM)患者,收集中入组时及随访中的癫痫发作数据。结果显示42%的患者曾有癫痫发作,儿童期累积发病率为20.3%,至80岁达60.4%;CCM数量更多或CCM3基因型者发作风险更高,且发作史与住院率增加相关。
要点
- FCCM患者癫痫发作常见,儿童期累积发病率20.3%,至80岁达60.4%。
- CCM3突变者癫痫风险约为其他突变者的3倍,发作史者住院率显著升高。
核心结论
- FCCM患者癫痫发病率高,CCM数量多或CCM3基因型者风险更高,癫痫发作增加医疗资源使用。
研究设计与样本
- 研究为队列研究,纳入BVMC中479例FCCM患者,入组时中位年龄42.5岁(四分位距22.5-55.0),19%为儿童。
主要发现
- 202例(42%)在入组前或研究期间有癫痫发作。
- 儿童期癫痫累积发病率为20.3%(95%CI 17.0-23.4),至80岁为60.4%(95%CI 54.2-65.7)。
- CCM总数每增加1个标准差,癫痫风险HR 1.24(95%CI 1.1-1.4);大CCM数每增加1个标准差,HR 1.5(95%CI 1.2-1.9)。
- CCM3突变者较其他突变者癫痫风险HR 3.11(95%CI 1.15-8.45)。
- 入组前有癫痫发作者随访期间住院率 incidence rate ratio 10.9(95%CI 2.41-49.32)。
关键数值与推荐
- 393例基因检测者中,CCM1(Common Hispanic Mutation)占88%,其他CCM1突变占5%,CCM2突变占5%,CCM3突变占2%。
临床怎么用
- 对FCCM患者应关注癫痫发作风险,尤其CCM数量多或CCM3基因型者,需加强监测与管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Seizure incidence rates related to familial cerebral cavernous malformation (FCCM) are not well described, especially for children. To measure the seizure incidence rate, examine seizure predictors, and characterize epilepsy severity, we studied a cohort of children and adults with FCCM enrolled in the Brain Vascular Malformation Consortium (BVMC). METHODS: Seizure data were collected from participants with FCCM in the BVMC at enrollment and during follow-up. We estimated seizure probability by age and tested whether cerebral cavernous malformation (CCM) counts or genotype were associated with earlier seizure onset. RESULTS: The study cohort included 479 FCCM cases. Median age at enrollment was 42.5 years (interquartile range 22.5-55.0) and 19% were children (<18 years old). Median large CCM count was 3 (interquartile range 1-5). Among 393 with genotyping, mutations were as follows: CCM1 (Common Hispanic Mutation) (88%), another CCM1 mutation (5%), CCM2 mutations (5%), and CCM3 mutations (2%). Prior to or during the study, 202 (42%) had a seizure. The cumulative incidence of a childhood seizure was 20.3% (95% confidence interval [CI] 17.0-23.4) and by age 80 years was 60.4% (95% CI 54.2-65.7). More total CCMs (hazard ratio [HR] 1.24 per SD unit increase, 95% CI 1.1-1.4) or more large CCMs (HR 1.5 per SD unit increase, 95% CI 1.2-1.9) than expected for age and sex increased seizure risk. A CCM3 mutation also increased risk compared to other mutations (HR 3.11, 95% CI 1.15-8.45). Individuals with a seizure prior to enrollment had increased hospitalization rates during follow-up (incidence rate ratio 10.9, 95% CI 2.41-49.32) compared to patients without a seizure history. DISCUSSION: Individuals with FCCM have a high seizure incidence and those with more CCMs or CCM3 genotype are at greater risk. Seizures increase health care utilization in FCCM.
引用
- Fox CK, Nelson J, McCulloch CE, et al. Seizure Incidence Rates in Children and Adults With Familial Cerebral Cavernous Malformations. Neurology. 2021. PMID: 34389651. doi:10.1212/WNL.0000000000012569
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。